Up to date, accumulating ACE2 agonists have been designed for many conditions, such as hypertension, myocardial Ischemia, type 2 diabetes mellitus, bone cancer, chondrosarcoma, and clear cell sarcoma of the kidney 27. Here, ACE2 is linked to diabetes mellitus.